Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacific Biosciences of California Inc (NASDAQ:PACB)

Thursday’s trading has closed, but PACB is being traded in the after-hours session. After-Hours quote »
8.94
Delayed Data
As of 3:59pm ET
 +0.155 / +1.77%
Today’s Change
3.58
Today|||52-Week Range
14.00
-31.95%
Year-to-Date

Today’s Trading

Previous close8.78
Today’s open8.67
Day’s range8.42 - 9.10
Volume1,268,565
Average volume (3 months)2,628,772
Market cap$702.3M
Dividend yield--
Data as of 3:59pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)+25.40%
Earnings growth (this year)+55.25%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+115.02%
P/E ratioNM
Price/Sales9.12
Price/Book11.81

Competitors

 Today’s
change
Today’s
% change
MNTAMomenta Pharmaceutic...+0.03+0.29%
RLYPRelypsa Inc+1.42+8.99%
AIMTAimmune Therapeutics...+0.49+3.17%
IMGNImmunoGen Inc+0.07+1.00%
Data as of 4:00pm ET, 02/11/2016

Financials

Next reporting dateApril 27, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$60.6M
Annual profit (last year)-$66.2M
Net profit margin-109.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Mike W. Hunkapiller
Executive VP, Chief Financial &
Accounting Officer
Susan K. Barnes
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers